Table 3.
Models | Odds Ratios (95% CI) | P value |
---|---|---|
Model 1 unadjusted | 1.95 (1.13–3.38) | 0.02 |
Model 2 | 1.91 (1.06–3.44) | 0.03 |
Model 3 | 1.97 (1.08–3.61) | 0.03 |
Subgroup analysis: Excluding subjects with cognitive impairment (CASI < 74) or prevalent clinical stroke at baseline | ||
Model 1 unadjusted | 2.10 (1.05–4.19) | 0.04 |
Model 2 | 2.33 (1.08–5.00) | 0.03 |
Model 3 | 2.47 (1.10–5.55) | 0.03 |
Subgroup analysis: Excluding subjects with cognitive impairment (CASI < 74) or prevalent clinical stroke at baseline or ApoE genotype positive* | ||
Model 1 unadjusted | 2.71 (1.07–6.89) | 0.04 |
Model 2 | 3.90 (1.26–12.10) | 0.02 |
Model 3 | 4.13 (1.22–14.00) | 0.02 |
Model #1 unadjusted.
Model #2 adjusted for age, education, ApoE4 genotype, large or small infarcts on MRI, and baseline CASI.
Model #3 adjusted for age, education, ApoE4 genotype, large or small infarcts on MRI, baseline CASI, baseline hypertension, time of follow-up.
Subgroup analyses excluding men with ApoE4 genotype were not adjusted for ApoE4.
Abbreviations: CASI=cognitive abilities screening instrument.